A naturally occurring gene called Cyclin A2 (CCNA2), which turns off after birth in humans, can actually make new, functioning heart cells and help the heart repair itself from injury, including a ...

Jupiter Endovascular, Inc., a medical technology company developing a new class of endovascular interventions using its proprietary Transforming Fixation (TFX) technology, today announced positive ...

Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and activity in the first half of 2026 ...

It lived at the foot of their bed, printing for hours while they were in class. “If you can imagine what body horror would ...

Scientists have known for decades that opioids relieve pain by binding to molecular switches in the brain called mu-opioid ...

His Highness Dr Sheikh Sultan Bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, witnessed the launch of ...

M42, a global health leader powered by technology, AI and genomics, has announced a strategic partnership with 10X Health (USA) and REVIV Global (UK) to launch 10XREVIV, a pioneering venture set to ...

SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. ('the Company” or 'Jade”), (Nasdaq: JBIO), a clinical-stage biotechnology company focused on ...

Until the arrival of the Hunter frigates in the 2030s, the most powerful Royal Australian Navy surface combatants are three ...